Bios Partners — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Cue Biopharmacuebiopharma.comNASDAQ: CUENov 2022SEC filingmedium confidence
BiotechBoston, US
Daniel Baker(Executive Officer)Colin Sandercock(Executive Officer)Dominic Borie(Executive Officer)Sumita Ray(Executive Officer)Daniel Camardo(Director)Viola Meehan(Director)
Board seatAaron G.L. Fletcher· per SEC Form D · $30M raise · filed Nov 2022
Lung Therapeuticslungtx.comMar 2022SEC filingmedium confidence
BiotechAustin, US
Aaron Fletcher(Director)Joseph Woelkers(Director)Steven Idell(Director)Robert Mills(Director)James Brian Windsor(President and CEO)
Board seatAaron G.L. Fletcher· per SEC Form D · $15M raise · filed Apr 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.